Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Lipid-core peptides may have efficacy as helminth vaccines

Dec. 3, 2012

New targets identified for malignant peripheral nerve sheath tumors

Dec. 3, 2012

GDC-0449 evaluated for new indication

Dec. 3, 2012

Novel mouse model of NSF developed at Thomas Jefferson University

Nov. 30, 2012

Preclinical and phase I data presented for AP-26113

Nov. 30, 2012

MM-938 significantly reduces tumor growth rates in glioblastoma mouse models

Nov. 30, 2012

First-in-human study of AT-406 described

Nov. 30, 2012

RVX-297 reduces clinical signs of disease in a rat model of rheumatoid arthritis

Nov. 30, 2012

PAX2 identified in CNS hemangioblastomas

Nov. 30, 2012

Proof-of-concept results reported for BAY-94-8862

Nov. 30, 2012

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...